Omeros (OMER) FCF Margin (2010 - 2026)
Omeros' (OMER) quarterly FCF Margin came in at 146.63% in Q1 2026, down 85.13% quarter-over-quarter from 79.2% in Q3 2021.
Omeros (OMER) FCF Margin (2010 - 2026) Analysis & Trends
Omeros has disclosed FCF Margin across 13 years of filings, most recently posting 146.63% for Q1 2026.
- FCF Margin for Q1 2026 came in at 146.63%, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was 137.93% (up 4109.0% YoY), and the FY2020 annual result was 135.98%, down 8195.0% from the prior year.
- FCF Margin came in at 146.63% for Q1 2026 at Omeros, down from 79.2% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 146.63% in Q1 2026 to a low of 146.63% in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -3.98% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 43.35% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Omeros | 737.87 Mn | 602.55 Mn | 9.31 Mn | -146.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -146.63% |
| Sep 30, 2021 | -79.20% |
| Jun 30, 2021 | -96.03% |
| Mar 31, 2021 | -191.19% |
| Dec 31, 2020 | -173.13% |
| Sep 30, 2020 | -134.08% |
| Jun 30, 2020 | -278.94% |
| Mar 31, 2020 | -39.12% |
| Dec 31, 2019 | -68.92% |
| Sep 30, 2019 | -25.32% |
| Jun 30, 2019 | -62.37% |
| Mar 31, 2019 | -60.29% |
| Dec 31, 2018 | -112.41% |
| Sep 30, 2018 | -802.13% |
| Jun 30, 2018 | -1,879.94% |
| Mar 31, 2018 | -722.86% |
| Dec 31, 2017 | -30.32% |
| Sep 30, 2017 | -51.84% |
| Jun 30, 2017 | -48.99% |
| Mar 31, 2017 | -104.22% |